Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Malignant Lymphoma

Free Subscription 27.10.2025 3 Br J Haematol 2 J Am Acad Dermatol 1 J Clin Oncol 1 Mod Pathol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Br J Haematol

1. SHICHIJO T, Tatetsu H, Higuchi Y, Miyakawa T, et al
   Prognostic impact of valemetostat in relapsed/refractory adult T-cell leukaemia-lymphoma.
   Br J Haematol. 2025 Oct 23. doi: 10.1111/bjh.70219.
   PubMed         Abstract available
   
   
2. SAROSIEK S, Suarez U, Fernandez-Turizo M, Sarosiek KA, et al
   BCL-2 inhibition in Waldenstrom macroglobulinaemia and marginal zone lymphoma.
   Br J Haematol. 2025 Oct 19. doi: 10.1111/bjh.70208.
   PubMed         Abstract available
   
   
3. ZHANG X, Wang L, Kuang N, Yang J, et al
   Immune reconstitution after CD7 CAR-T cell therapy for refractory/relapsed acute T-lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T-ALL/LBL).
   Br J Haematol. 2025 Oct 19. doi: 10.1111/bjh.70201.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

4. COHEN LS, Adeuyan O, Margolis DJ, Kim EJ, et al
   Medicare coverage of home phototherapy units for cutaneous T-cell lymphoma versus psoriasis.
   J Am Acad Dermatol. 2025 Oct 17:S0190-9622(25)03027.
   PubMed        
   
   
5. KIM DY, Peacker BL, Dang TM, Shinohara MM, et al
   Clinical Presentation and Survival Outcomes of Primary Cutaneous T-Cell Lymphoma Among Disaggregated Asian American, Native Hawaiian, and Pacific Islander Populations.
   J Am Acad Dermatol. 2025 Oct 15:S0190-9622(25)03015.
   PubMed        
   
   

   
   J Clin Oncol

6. HUTCHINGS M, Sureda A, Bosch F, Larsen TS, et al
   Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial.
   J Clin Oncol. 2025 Oct 20:JCO2500992. doi: 10.1200/JCO-25-00992.
   PubMed         Abstract available
   
   

   
   Mod Pathol

7. GUO Z, Su J, Liu L, Zhang N, et al
   CD180 as a Robust Immunophenotypic Marker for Differentiating Lymphoplasmacytic Lymphoma/ Waldenstrom Macroglobulinemia from Marginal Zone Lymphoma.
   Mod Pathol. 2025 Oct 15:100919. doi: 10.1016/j.modpat.2025.100919.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.